Thursday 4 March
Friday 5 March
Tuesday 30 March
- Medicines - Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V via an open-house model for the active substance Oxycodone/Naloxone (WHO ATC code: N02AA55)
- Medicines - Open-House rebate agreements 2025-02
- Physician practice services - AOK - Priomed secondary prevention under Section 140a SGB V